Navigation Links
Repeated Liver Cell Proliferation, a Cause for Liver Cancer

According to researchers at the University of California, San Diego (UCSD) School of Medicine, liver cancer can possibly be caused by cycles of liver cell// death and renewal – liver cell proliferation.

The research, appearing online the week of June 19 in advance of publication in the journal Proceedings of the National Academy of Sciences, underscores the importance of JNK1-mediated cell death and compensatory proliferation. The findings by Michael Karin, Ph.D., professor pharmacology in UCSD?|s Laboratory of Gene Regulation and Signal Transduction, and colleagues strongly suggest that the control of tissue renewal through the IKK and JNK pathways plays a key role in liver cancer in mouse models.

One link between inflammation and cancer is known to involve the NF-kB pathway, which regulates gene expression. In research published in the journal Cell in 2005, Karin and his colleagues at UCSD implicated the pathway's activator, IKK , in chemically induced liver cancer. However, the surprising outcome of those studies was the finding that while NF-??B activation in hepatocytes (liver cells) prevents liver cancer, its activation in inflammatory cells, such as tissue macrophages, promotes tumor development.

In their latest work, the research team studied what precedes inflammation ?V the injury of hepatocytes caused by toxic chemicals, which sets in motion the inflammation process.

Their research showed that the absence of IKK?ò in hepatocytes led to increased c-Jun N-terminal kinase (JNK) activation after exposure to a chemical carcinogen used to elicit liver cancer in mice. Importantly, deletion of the gene that codes for the major isoform of JNK in liver cells, JNK1, prevented the development of liver cancer and reversed the tumor-enhancing effect caused by ablation of IKK?ò.

"We found that long-term JNK activation leads to cell death; if activated briefly, it stimulates proliferation of pre-malignant and cancerous tu mor cells," said Karin. Blocking JNK prevents liver injury but also inhibits liver regeneration, so the timing and context of activation are very important, he added.

"In this research, we set out to identify what causes inflammation in response to liver injury, as well as what stimulates the proliferation of surviving hepatocytes," said Karin. "Since we previously knew that JNK activity is required for normal liver cell proliferation, we wondered if the same activity is required for production of liver cancer in carcinogen-exposed mice. The results were clear JNK1 is critical for tumor development."

The scientists genetically removed JNK1 to test if its increased activation, caused by the absence of IKK?ò, was responsible for accelerated tumor development. When JNK1 was removed, the number and size of cancerous liver tumors decreased, and the tumors grew more slowly. Increased JNK1 activation was found in diseased liver and tumors when compared to normal tissue.

Hepatocellular carcinoma (HCC), the most common form of liver cancer, is the third leading cause of cancer deaths worldwide. Its major risk factors are persistent infection with hepatitis B and C viruses, and exposure to toxic chemicals, including alcohol ?V all of which cause chronic liver injury and inflammation. Although not common in the United States., the incidence of HCC is on an upward trajectory, with little hope for treatment or cure through chemotherapy, radiation or other traditional cancer treatments.

"We now understand development of liver cancer in mice. Since inflammation drives both damage and regeneration in liver tissue, it is the repeating cycle of damage, inflammation and regeneration that leads to liver cancer," said Karin. "However, this knowledge is not satisfactory until we find out if it applies to humans."

Source: Eurekaert
'"/>




Related medicine news :

1. New Findings for Repeated Miscarriages
2. Repeated checking causes memory distrust
3. Repeated Heart Surgery with Older Blood Transfusion Pack More Death Risk
4. Repeated Weight loss Messages Have No Effect On Couch Potatoes
5. Genes May Trigger Repeated Premature Birth In Blacks
6. Blood Cells Capable of Regenerating Liver
7. Liver donors can thrive after transplant
8. Heavy Drinking Raises Risk of Liver Cancer
9. Arthritis Drug May Cause Liver Damage
10. Liver transplant oversight urged
11. Liver key to extending life
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... industry leader in Blood Pressure products . , High blood pressure affects ... effects. Left untreated, high blood pressure can lead to heart disease, stroke, kidney ...
(Date:5/26/2016)... ... May 26, 2016 , ... With long-term ... Vice President of Business Intelligence and Informatics, effective immediately. http://www.fluidedgeconsulting.com , ... teams as a healthcare business and financial strategist for over 20 years. ...
(Date:5/25/2016)... ... May 26, 2016 , ... The 12th session of ... 7.30pm PST at HP in Palo Alto, CA. This Bay Area biotech event will ... by clinical trial experts from the pharmaceutical company Hallux, biopharma Apexigen, Contract Research Organization ...
(Date:5/25/2016)... ... May 25, 2016 , ... Extremity Healthcare, Incorporated has implemented ... patient check-in and post visit surveys. , “The Phreesia front desk system has ... revolutionized the check-in process for our clinic network, providing a world class administration ...
(Date:5/25/2016)... ... 25, 2016 , ... Serenity Recovery, a holistic treatment center ... of the many supplemental program options offered at their rehabilitation facility, this time ... Black Belt in the Shorin-ryu style of Karate that originated in Okinawa, Japan, ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... CORAL SPRINGS, Florida , May 25, 2016 /PRNewswire/ ... Marijuana Business Conference & Expo earlier this month, the ... undeniable. As revenues continue to climb into the billions, ... to the newly released 4th Edition State of Legal ... New Frontier, a cannabis-focused data-analysis firm, much of the ...
(Date:5/25/2016)... 25, 2016 MedDay, a biotechnology company ... an oral presentation entitled "High doses of biotin in progressive ... be given by Professor Ayman Tourbah , Principal Investigator ... the European Academy of Neurology (EAN) in Copenhagen, ... 3" will take place on Sunday, 29 May 2016 from ...
(Date:5/24/2016)... May 24, 2016 Niederländische ... gebracht, die es Ärzten erlaubt, ihre Expertise weltweit ... MDLinking kombiniert Live Streaming mit einer Instant-Messaging-Funktion und ... kommunizieren. Mediziner in Europa, Afrika, Asien und den ... für die Plattform registriert. Information und ...
Breaking Medicine Technology: